| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.40B | +8.4% |
| Gross profit | ¥0.21B | — |
| Operating income | ¥0.15B | — |
| Net income | ¥0.11B | +75.0% |
| Gross margin | 51.6% | Net margin 28.3% |
| Revenue Q/Q | -1.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 48.4% |
| R&D | ¥0.00B | 0.4% |
| SG&A | ¥0.03B | 7.9% |
| Tax & other | ¥0.04B | 8.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies